Correlation Engine 2.0
Clear Search sequence regions


  • activity (4)
  • antigens (2)
  • apoptosis (1)
  • CD16 (2)
  • CD4 (2)
  • cells (1)
  • factors (2)
  • female (1)
  • FOXP3 (2)
  • functions (1)
  • human (3)
  • immunity cellular (1)
  • lymphocyte (5)
  • male (1)
  • monocyte (2)
  • nk cells (2)
  • nkt cells (1)
  • pregnancy (3)
  • PSG (8)
  • t cells (1)
  • vitro (1)
  • Sizes of these terms reflect their relevance to your search.

    Effect of human Pregnancy specific β1-glycoprotein (PSG) in physiological concentrations was analyzed against the expression of natural killer (NK)-, T-cells with natural killer functions (N KT-) and T-regulatory lymphocyte (Treg) markers, as well as on the activity of monocyte indolamine-2,3-dioxygenase (IDO) and lymphocyte apoptosis in vitro. It was revealed that PSG in high concentration (100 μg/mL) suppressed the CD16/56 expression by NK-cells, while inhibiting the cytolytic activity of these cells. Meanwhile, PSG in low concentrations (1 and 10 μg/mL) enhanced the CD16/56 expression by NKT-cells that was related to cytokine-producing activity. It was found that PSG increased the number of adaptive Tregs in culture (CD4+FOXP3+ and CD4+CD25(bright)FOXP3+). In addition, PSG promoted the IDO activity in peripheral monocytes, while further potentiating the Treg generation. In general, PSG rendered anti-apoptotic action on lymphocytes. Therefore, indicated effects can determine the PSG contribution to the development of immune tolerance in pregnancy.

    Citation

    S A Zamorina, M B Raev. The study of human pregnancy specific β1-glycoprotein immunomodulating effects]. Fiziologiia cheloveka. 2015 Jan-Feb;41(1):117-23

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 25857185

    View Full Text